This clinical trial is focused on understanding how certain medications affect breathing. The study involves healthy individuals and examines the effects of a pain medication called fentanyl, which is known to sometimes cause breathing difficulties, a condition known as opioid-induced respiratory depression. The trial also investigates the use of another medication, acetylcysteine (also referred to as L-NAC), which is being tested to see if it can help improve breathing when fentanyl is used.
Participants in the study will receive these medications through an intravenous infusion, which means the drugs are delivered directly into the bloodstream through a vein. The study will also use a placebo for comparison. The main goal is to see if acetylcysteine can help reverse the breathing problems caused by fentanyl. Additionally, the study will monitor various aspects of breathing, such as how much air is inhaled and exhaled in a minute, the levels of carbon dioxide in the breath, and other related measures.
The trial will take place over a short period, with participants receiving the treatments and being closely monitored for any changes in their breathing patterns. The study aims to provide valuable insights into how these medications interact and whether acetylcysteine can be an effective treatment for breathing issues caused by opioid medications like fentanyl.



The Netherlands